Abstract Overview: Efficacy of Vemurafenib in NSCLC Patients

Abstract Overview: Efficacy of Vemurafenib in NSCLC Patients

User Photo
AnnualMeeting2017

3 years
2,654 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Vivek Subbiah, MD of MD Anderson Cancer Center gives an overview of his presentation, which focused on the use of vemurafenib in patients with non small-cell lung cancer. This was recorded at the 2017 ASCO Annual Meeting in Chicago, IL. Abstract 9074: Efficacy of vemurafenib in patients (pts) with non-small cell lung cancer (NSCLC) with BRAFV600mutation.
Up Next Autoplay